Joint Formulary & PAD

Mizolastine - Allergic rhinitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :
Important
Discontinued April 2024. Refer to guidelines for alternatives.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Mizolastine
Indication :
Allergic rhinitis
Group Name :
Keywords :
Hay fever, hayfever, antihistamines, allergy, seasonal allergic rhinitis, pollen allergy, non-sedating antihistamines
Brand Names Include :
Mizollen
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Mizolastine is used to treat.

  • No records returned.

Committee Recommendations (1)

28 May 24 - Not Set

Mizolastine has been discontinued - Apr 2024.

Please refer to the local hay fever guidelines for alternatives